The FDA has approved Adcetris (brentuximab vedotin) for use in combination with lenalidomide and rituximab to treat patients with relapsed/refractory LBCL after 2 or more lines of systemic therapy who ...

Pfizer Inc. (NYSE: PFE) announced today that the U.S. Food and Drug Administration (FDA) has approved the supplemental Biologics License Application ...

Areas scarred by the Eaton Fire are at “high to very high risk” of debris flows this week. How do they happen? What is being ...

Blood tests are a routine part of your prenatal care. Here's everything you need to know about what you can expect.

Teddi Mellencamp revealed a devastating health update on Wednesday and shared 'multiple tumors' were found on her brain - ...